Monoclonal antibodies to CD40 ligand, pharmaceutical composition

Details Monoclonal antibodies to CD40 ligand, pharmaceutical composition Monoclonal antibodies to CD40 ligand, pharmaceutical composition

1994-05-24

1999-10-05

Chan, Christina Y.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

4241301, 4241411, 4241431, 4241441, 4241531, 4241731, 435 7021, 435452, 435326, 435332, 435334, 435343, 4353431, 4353432, 435346, 5303871, 5303879, 5303881, 53038822, 5303887, 53038873, 53038875, C07K 1628, A61K 39395, C12N 512

Patent

active

059619740

ABSTRACT:
There is disclosed a polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor.

REFERENCES:
patent: 5182368 (1993-01-01), Ledbetter et al.
patent: 5247069 (1993-09-01), Ledbetter et al.
patent: 5474771 (1995-12-01), Lederman et al.
patent: 5876950 (1999-03-01), Siadak et al.
Lederman et al. J Exp Med 175: 1091-1101 (1992).
6.sup.th International Workshop and Conference on Human Leukocyte Differentiation Antigens (Nov. 10-14, 1996) Kobe Japan, Proceedings, Fanslow et al, pp. 101-103.
6.sup.th International Workshop and Conference on Human Leukocyte Differentiation Antigens, Kobe Japan, Abstracts, vol. 48, No. 4--Part II, p. 477, TC-3-01 to TC-3-03 (Oct. 1996).
6.sup.th International Workshop and Conference on Human Leukocyte Differentiation Antigens, Kobe Japan, Abstract #381, Program TC-3-01, Armitage et al (Oct. 1996).
Casamayor-Palleja et al, J. Exp. Med., 181:1293-1302 (1995).
HLDA Antibody Database--Antibodies Assigned to CD154 (1998).
Aruffo and Seed, Proc. Natl. Acad. Sci. USA 84:8573, 1987.
Stamenkovic et al., EMBO J.8:1403, 1989.
Zettlmeissl et al., DNA Cell. Biol. 9:347, 1990.
Banchereau et al., Science 251:70, 1991.
Rousset et al., J. Exp. Med. 173:705, 1991.
Banchereau and Rousset, Clinical Immunology Spectrum 3:9, 1991.
Liu et al., Nature 342:929, 1989.
Ghaderi et al., Immunology 73:510, 1991.
Kikutani et al., Cell 47:657, 1986.
Wang et al., J. Virol. 65:4101, 1991.
Valle et al., Eur. J. Immunol. 19:1463, 1989.
Clark et al., Proc. Natl. Acad. Sci. USA 83:4494, 1986.
Paulie et al., J. Immunol. 142:590, 1989.
Gordon et al., Eur. J. Immunol. 17:1535, 1987.
Jabara et al., J. Exp. Med. 172:1861, 1990.
Zhang et al., J. Immunol. 146:1836, 1991.
Gascan et al., J. Immunol. 147:8, 1991.
Gordon et al., J. Immunol. 140:1425, 1988.
Armitage et al., Nature 357:80, 1992.
Fanslow et al., J. Immunol. 149:655, 1992.
Spriggs et al., J. Exp. Med. 176:1543, 1992.
Farrah and Smith, Nature 358:26, 1992.
Noelle et al., Proc. Natl. Acad. Sci. USA 89:6550, 1992.
Hollenbaugh et al., EMBO J. 11:4313, 1992.
Durie et al., Science 261:1328; 1993.
Lauzon et al, Mol. Immunol. 25:829; 1988.

Affiliated with

Also associated with

Rating

Monoclonal antibodies to CD40 ligand, pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies to CD40 ligand, pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies to CD40 ligand, pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1168337